Tezepelumab administration in moderate-to-severe uncontrolled asthma: is it all about eosinophils? Puzzovio PG, Eliashar R, Levi-Schaffer F. J Allergy Clin Immunol 2022 Feb 8. pii: S0091-6749(22)00145.

Read + Share

Amedeo Smart

Independent Medical Education

Puzzovio PG, Eliashar R, Levi-Schaffer F. Tezepelumab administration in moderate-to-severe uncontrolled asthma: is it all about eosinophils? J Allergy Clin Immunol 2022 Feb 8. pii: S0091-6749(22)00145.
PMID: 35149043